Last reviewed · How we verify

GnRh agonist +1500E hCG — Competitive Intelligence Brief

GnRh agonist +1500E hCG (GnRh agonist +1500E hCG) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: GnRH agonist with hCG supplementation. Area: Reproductive/Fertility.

marketed GnRH agonist with hCG supplementation GnRH receptor; LH receptor (via hCG) Reproductive/Fertility Small molecule Live · refreshed every 30 min

Target snapshot

GnRh agonist +1500E hCG (GnRh agonist +1500E hCG) — AZ Jan Palfijn Gent. A GnRH agonist combined with hCG that stimulates the pituitary-gonadal axis to increase gonadotropin secretion and sex hormone production.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
GnRh agonist +1500E hCG TARGET GnRh agonist +1500E hCG AZ Jan Palfijn Gent marketed GnRH agonist with hCG supplementation GnRH receptor; LH receptor (via hCG)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (GnRH agonist with hCG supplementation class)

  1. AZ Jan Palfijn Gent · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). GnRh agonist +1500E hCG — Competitive Intelligence Brief. https://druglandscape.com/ci/gnrh-agonist-1500e-hcg. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: